Kolon Life Science
Korea - SeoulBiotechnology
Focus: Kolon Life Science is a Korean biotech company specializing in cell and gene therapy, as well as active pharmaceutical ingredients (APIs). The company operates as a mid-cap biotech player focused on advanced therapeutic modalities.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Kolon Life Science
AI assessmentNot HiringNo open roles listed right now. Follow Kolon Life Science to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
A Post Marketing Surveillance Study of INVOSSA K Inj.
OsteoarthritisClinical Trials (1)
NCT03412864A Post Marketing Surveillance Study of INVOSSA K Inj.
N/AHelp build intelligence for Kolon Life Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.